Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

NUVB Panacea Acquisition Corp

2,66

0,07 (2,70%)

Vor Marktöffnung

Zuletzt aktualisiert: 14:02:37

Verzögert um 15 Minuten

Form ARS - Annual Report to Security Holders

Panacea Acquisition (NYSE:NUVB)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Panacea Acquisition Charts.

Panacea Acquisition (NYSE:NUVB)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Panacea Acquisition Charts.

News Panacea Acquisition Corp

U.S. Food and Drug Administration Accepts for Priority Review Nuvation Bio’s New Drug Application for Taletrectinib for the Treatment of Advanced ROS1-positive Non-Small Cell Lung Cancer
Montag 23 Dezember 2024 (2 Wochen vor) • Business Wire

Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration
Freitag 20 Dezember 2024 (2 Wochen vor) • PR Newswire (US)

Nuvation Bio to Present at the 7th Annual Evercore ISI HealthCONx Conference
Dienstag 26 November 2024 (1 Monat vor) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 13 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Nuvation Bio to Present at the Jefferies London Healthcare Conference
Dienstag 12 November 2024 (2 Monate vor) • Business Wire

Form 8-K - Current report
Mittwoch 6 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mittwoch 6 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Nuvation Bio Reports Third Quarter 2024 Financial Results and Provides Business Update
Mittwoch 6 November 2024 (2 Monate vor) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 10 Oktober 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 9 Oktober 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Mittwoch 9 Oktober 2024 (3 Monate vor) • Edgar (US Regulatory)

Nuvation Bio Appoints Industry Veteran Philippe Sauvage as Chief Financial Officer
Montag 7 Oktober 2024 (3 Monate vor) • Business Wire

Weitere Panacea Acquisition Corp News-Artikel

Azienda Gardesana Servizi

Societe Generale

BNP Paribas Issuance

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen